Patricia D Hurn

Title: Patricia D Hurn: Innovator in Neurotoxicity Treatment

Introduction

Patricia D Hurn is a distinguished inventor based in Upperco, Maryland. She has made significant contributions to the field of neurotoxicity treatment through her innovative research and patent.

Latest Patents

Hurn holds a patent for a method of using selective PARP inhibitors to prevent or treat neurotoxicity. This patent addresses neutral tissue damage resulting from ischemia and reperfusion injury or neurodegenerative diseases. The method involves administering therapeutically effective amounts of certain selective inhibitors of poly(ADP-ribose) polymerase. These inhibitors can be delivered through various routes, including intravenously, intraperitoneally, intramuscularly, intraventricularly, or orally. They can be provided in the form of capsules or tablets containing single or divided doses, or as a sterile solution, suspension, or emulsion.

Career Highlights

Hurn is affiliated with The Johns Hopkins University, where she continues her research and development in the field of neurotoxicity. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from neurodegenerative conditions.

Collaborations

Hurn has collaborated with notable colleagues, including Mikael J Eliasson and Kenji Sampei, to advance her research and explore new therapeutic avenues.

Conclusion

Patricia D Hurn's innovative work in the field of neurotoxicity treatment exemplifies her commitment to advancing medical science. Her contributions through her patent and collaborations highlight her role as a leading inventor in this critical area of research.